Xia LP - Search Results

1

Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers.

Yang L, He W, Kong P, Jiang C, Yang Q, Xie Q, Xia LP. Yang L, et al. Among authors: xia lp. BMC Cancer. 2017 Dec 20;17(1):873. doi: 10.1186/s12885-017-3862-8. BMC Cancer. 2017. PMID: 29262803 Free PMC article.

2

Lymph node ratio and pN staging show different superiority as prognostic predictors depending on the number of lymph nodes dissected in Chinese patients with luminal A breast cancer.

Wang F, He W, Qiu H, Wang X, Guo G, Chen X, Rong Y, Zhou F, Yin C, Yuan Z, Xia L. Wang F, et al. Clin Breast Cancer. 2012 Dec;12(6):404-11. doi: 10.1016/j.clbc.2012.07.009. Epub 2012 Sep 29. Clin Breast Cancer. 2012. PMID: 23026023

3

Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer.

He W, Yin C, Guo G, Jiang C, Wang F, Qiu H, Chen X, Rong R, Zhang B, Xia L. He W, et al. Med Oncol. 2013 Mar;30(1):439. doi: 10.1007/s12032-012-0439-x. Epub 2013 Jan 10. Med Oncol. 2013. PMID: 23307251

4

Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancer.

Yin C, Jiang C, Liao F, Rong Y, Cai X, Guo G, Qiu H, Chen X, Zhang B, He W, Xia L. Yin C, et al. Onco Targets Ther. 2014 Aug 11;7:1415-22. doi: 10.2147/OTT.S64559. eCollection 2014. Onco Targets Ther. 2014. PMID: 25143746 Free PMC article.

5

Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer.

Yang Q, Yin C, Liao F, Huang Y, He W, Jiang C, Guo G, Zhang B, Xia L. Yang Q, et al. Onco Targets Ther. 2015 Sep 1;8:2407-13. doi: 10.2147/OTT.S88679. eCollection 2015. Onco Targets Ther. 2015. PMID: 26366095 Free PMC article.

6

A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C.

Liao F, He W, Jiang C, Yin C, Guo G, Chen X, Qiu H, Rong Y, Zhang B, Xu D, Xia L. Liao F, et al. Onco Targets Ther. 2015 Oct 27;8:3135-42. doi: 10.2147/OTT.S90479. eCollection 2015. Onco Targets Ther. 2015. PMID: 26604782 Free PMC article.

7

Longterm effects of palliative local treatment of incurable metastatic lesions in colorectal cancer patients.

Yang Q, Liao F, Huang Y, Jiang C, Liu S, He W, Kong P, Zhang B, Xia L. Yang Q, et al. Oncotarget. 2016 Apr 12;7(15):21034-45. doi: 10.18632/oncotarget.8090. Oncotarget. 2016. PMID: 26992234 Free PMC article.

8

Prognostic Impact of the Signet Ring Cell Type in Node-Negative Gastric Cancer.

Kong P, Wu R, Yang C, Geng Q, Liu J, Chen S, Liu X, Ye M, He W, Yang Q, Xia L, Xu D. Kong P, et al. Sci Rep. 2016 Jul 6;6:26313. doi: 10.1038/srep26313. Sci Rep. 2016. PMID: 27381549 Free PMC article.

9

Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis.

Yang L, Xia L, Wang Y, Hong S, Chen H, Liang S, Peng P, Chen Y. Yang L, et al. PLoS One. 2016 Jul 11;11(7):e0158853. doi: 10.1371/journal.pone.0158853. eCollection 2016. PLoS One. 2016. PMID: 27399281 Free PMC article.

10

The Efficacy of Bevacizumab in Different Line Chemotherapy for Chinese Patients with Metastatic Colorectal Cancer.

Yin C, Ma G, Rong Y, Kong P, Yang Q, Jiang C, Liao F, Zhang B, He W, Xia L. Yin C, et al. J Cancer. 2016 Sep 13;7(13):1901-1906. doi: 10.7150/jca.15802. eCollection 2016. J Cancer. 2016. PMID: 27698931 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters